This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignee: Lonza Inc.. Active years: 1993-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brig-Glis, CH (1993 - 1994)
- Brig, CH (1994)
Company Filing History:
Years Active: 1993-1994
Title: Innovations by Inventor Markus Banziger
Introduction
Markus Banziger is a notable inventor based in Brig-Glis, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of active compounds. With a total of 5 patents to his name, Banziger's work has had a considerable impact on medicinal chemistry.
Latest Patents
Among his latest patents, Banziger has developed a process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide, a cerebrally active pharmaceutical agent. This innovative process involves the reaction of a 4-halo-3-alkoxy-butenoic acid ester with glycine to create new intermediate products. The method further includes acid hydrolysis of the alkoxy group, subsequent hydrogenation, esterification of the carboxyl function, and finally conversion to the end product through a reaction with ammonia. Another significant patent involves the production of optically-active 4-amino-3-hydroxy-carboxylic acids, particularly statine, starting from 5-alkylidene or 5-benzylidenetetramic acid. This synthesis process includes O-acylation, stereoselective hydrogenation, and enantioselective enzymatic hydrolysis to achieve the desired configuration.
Career Highlights
Markus Banziger is currently associated with Lonza Inc., a leading global company in the pharmaceutical and biotechnology sectors. His work at Lonza has allowed him to focus on innovative processes that enhance the production of vital pharmaceutical compounds. Banziger's expertise in medicinal chemistry has positioned him as a key player in the development of new therapeutic agents.
Collaborations
Throughout his career, Banziger has collaborated with notable colleagues such as John McGarrity and Thomas Meul. These collaborations have fostered an environment of innovation and have contributed to the advancement of pharmaceutical research.
Conclusion
Markus Banziger's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new and effective medicinal compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile